NO20081550L - Preventivt eller terapeutisk middel for sykdom forarsaket av minskning i lakrimalvaeske - Google Patents
Preventivt eller terapeutisk middel for sykdom forarsaket av minskning i lakrimalvaeskeInfo
- Publication number
- NO20081550L NO20081550L NO20081550A NO20081550A NO20081550L NO 20081550 L NO20081550 L NO 20081550L NO 20081550 A NO20081550 A NO 20081550A NO 20081550 A NO20081550 A NO 20081550A NO 20081550 L NO20081550 L NO 20081550L
- Authority
- NO
- Norway
- Prior art keywords
- reduction
- tears
- preventive
- therapeutic agent
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Foreliggende oppfinnelse tilveiebringer farmasøytiske midler for hindring eller behandling av sykdommer assosiert med tårereduksjon. Dvs. foreliggende oppfinnelse tilveiebringer farmasøytiske midler for hindring eller behandling av sykdommer assosiert med reduksjon av tårer slik som tørt øye, tørre forstyrrelser vedrørende hornhinne og conjunctiva, forstyrrelser vedrørende keratoconjunctival epitelium, syndrom med reduksjon i tåresekresjon, xeroftalmi, tørt øye på grunn av aldring, oftalmomopati ved Stevens-Johnson syndrom, oftalmopati ved Sjögrens syndrom, keratoconjunctival ulcer, tørrhet ved bruk av kontaktlinser eller lignende, som innebefatter en ?3-adrenoseptorstimulant. Foreliggende oppfinnelse tilveiebringer også et kombinasjonsfarmasøytisk middel som innebefatter en ?3-adrenoseptorstimulant og en ?2-adrenoseptorstimulant.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005247563 | 2005-08-29 | ||
PCT/JP2006/316836 WO2007026630A1 (ja) | 2005-08-29 | 2006-08-28 | 涙液の減少に伴う疾患の予防又は治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20081550L true NO20081550L (no) | 2008-05-28 |
Family
ID=37808722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20081550A NO20081550L (no) | 2005-08-29 | 2008-03-31 | Preventivt eller terapeutisk middel for sykdom forarsaket av minskning i lakrimalvaeske |
Country Status (14)
Country | Link |
---|---|
US (1) | US20100197788A9 (no) |
EP (1) | EP1938837A4 (no) |
JP (1) | JPWO2007026630A1 (no) |
KR (1) | KR20080038412A (no) |
CN (1) | CN101252952A (no) |
AU (1) | AU2006285963A1 (no) |
BR (1) | BRPI0615339A2 (no) |
CA (1) | CA2619445A1 (no) |
IL (1) | IL189620A0 (no) |
NO (1) | NO20081550L (no) |
RU (1) | RU2008112176A (no) |
TW (1) | TW200744635A (no) |
WO (1) | WO2007026630A1 (no) |
ZA (1) | ZA200801858B (no) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007061114A1 (ja) * | 2005-11-28 | 2007-05-31 | Kissei Pharmaceutical Co., Ltd. | 神経因性疼痛の予防又は治療用医薬組成物 |
WO2007114315A1 (ja) * | 2006-03-30 | 2007-10-11 | Santen Pharmaceutical Co., Ltd. | 角結膜障害治療剤 |
EP2123268A1 (en) * | 2007-02-21 | 2009-11-25 | Kissei Pharmaceutical Co., Ltd. | Pharmaceutical composition for prevention or treatment of disease associated with tear reduction |
JPWO2010041568A1 (ja) | 2008-10-09 | 2012-03-08 | 旭化成ファーマ株式会社 | インダゾール誘導体 |
AU2009301798B2 (en) | 2008-10-09 | 2012-03-01 | Asahi Kasei Pharma Corporation | Indazole compound |
US20100222404A1 (en) * | 2008-11-04 | 2010-09-02 | Asahi Kasei Pharma Corporation | Indazole derivative dihydrochloride |
US8778998B2 (en) | 2009-04-10 | 2014-07-15 | Auspex Pharmaceuticals, Inc. | Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor |
EP2506843A4 (en) * | 2009-12-02 | 2013-04-17 | Bridge Pharma Inc | TREATMENT OF THE DRY EYE WITH COMPOUNDS TO INCREASE MOMENTUM DRY SECRETION |
WO2014108449A1 (en) | 2013-01-08 | 2014-07-17 | Atrogi Ab | A screening method, a kit, a method of treatment and a compound for use in a method of treatment |
GB201612165D0 (en) * | 2016-07-13 | 2016-08-24 | Atrogi Ab | Combinations for the treatment of type 2 diabetes |
GB201714745D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714736D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714740D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5768684A (en) * | 1994-03-04 | 1998-06-16 | Motorola, Inc. | Method and apparatus for bi-directional power control in a digital communication system |
KR980007105A (ko) * | 1996-06-28 | 1998-03-30 | 김광호 | 이동국 송신전력 제어방법 |
ID24062A (id) * | 1997-07-25 | 2000-07-06 | Kissei Pharmaceutical | Turunan-turunan asam aminoetilfenoksiasetat dan obat untuk mengurangi nyeri dan membantu penyingkiran dalam litiasis saluran air kencing |
MY126489A (en) * | 1998-07-08 | 2006-10-31 | Kissei Pharmaceutical | Phenoxyacetic acid derivatives and medicinal compositions containing the same |
US6064659A (en) * | 1998-07-10 | 2000-05-16 | Motorola, Inc. | Method and system for allocating transmit power to subscriber units in a wireless communications system |
JP3471662B2 (ja) * | 1998-08-28 | 2003-12-02 | 松下電器産業株式会社 | 送受信装置及びその送信電力制御方法 |
US6311070B1 (en) * | 1999-03-22 | 2001-10-30 | Nortel Networks Limited | Variable step size for power control bits to protect against power overshoot |
EP1045529B1 (en) * | 1999-04-12 | 2006-11-29 | Alcatel | A method for improving performances of a mobile radiocommunication system using a power control algorithm |
WO2001041806A1 (fr) | 1999-12-07 | 2001-06-14 | Rohto Pharmaceutical Co., Ltd. | Compositions ophtalmiques |
KR100324425B1 (ko) * | 1999-12-29 | 2002-02-27 | 박종섭 | Cdma 시스템에서의 기지국 및 이동국간 순방향/역방향링크 전력제어 방법 |
JP2001268637A (ja) * | 2000-03-15 | 2001-09-28 | Nec Corp | 移動機及び基地局並びにそれ等を用いた移動通信システム |
CA2313290A1 (en) * | 2000-06-30 | 2001-12-30 | Frank Van Heeswyk | Adaptive rate power control cdma system |
US6856644B1 (en) * | 2000-10-31 | 2005-02-15 | Motorola, Inc. | Method and apparatus for forward link power control bit generation in a spread-spectrum communication system |
JP3577021B2 (ja) * | 2001-09-12 | 2004-10-13 | 埼玉日本電気株式会社 | 移動局および移動局における電界状態判定方法 |
AU2004212381B2 (en) | 2003-02-14 | 2008-08-21 | Kissei Pharmaceutical Co., Ltd. | Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof |
-
2006
- 2006-08-28 CA CA002619445A patent/CA2619445A1/en not_active Abandoned
- 2006-08-28 KR KR1020087006579A patent/KR20080038412A/ko not_active Application Discontinuation
- 2006-08-28 AU AU2006285963A patent/AU2006285963A1/en not_active Abandoned
- 2006-08-28 RU RU2008112176/15A patent/RU2008112176A/ru not_active Application Discontinuation
- 2006-08-28 JP JP2007533219A patent/JPWO2007026630A1/ja not_active Withdrawn
- 2006-08-28 EP EP06796870A patent/EP1938837A4/en not_active Withdrawn
- 2006-08-28 ZA ZA200801858A patent/ZA200801858B/xx unknown
- 2006-08-28 CN CNA2006800318183A patent/CN101252952A/zh active Pending
- 2006-08-28 BR BRPI0615339-9A patent/BRPI0615339A2/pt not_active IP Right Cessation
- 2006-08-28 WO PCT/JP2006/316836 patent/WO2007026630A1/ja active Application Filing
- 2006-08-29 TW TW095131667A patent/TW200744635A/zh unknown
-
2008
- 2008-02-19 US US12/070,495 patent/US20100197788A9/en not_active Abandoned
- 2008-02-20 IL IL189620A patent/IL189620A0/en unknown
- 2008-03-31 NO NO20081550A patent/NO20081550L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA200801858B (en) | 2009-07-29 |
US20080306160A1 (en) | 2008-12-11 |
WO2007026630A1 (ja) | 2007-03-08 |
JPWO2007026630A1 (ja) | 2009-03-05 |
CN101252952A (zh) | 2008-08-27 |
IL189620A0 (en) | 2008-06-05 |
KR20080038412A (ko) | 2008-05-06 |
BRPI0615339A2 (pt) | 2011-05-17 |
CA2619445A1 (en) | 2007-03-08 |
US20100197788A9 (en) | 2010-08-05 |
EP1938837A1 (en) | 2008-07-02 |
AU2006285963A1 (en) | 2007-03-08 |
RU2008112176A (ru) | 2009-10-10 |
TW200744635A (en) | 2007-12-16 |
EP1938837A4 (en) | 2010-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20081550L (no) | Preventivt eller terapeutisk middel for sykdom forarsaket av minskning i lakrimalvaeske | |
DK2170857T3 (da) | 3',4',5-trimethoxyflavonderivater som stimulerende middel ved slimafsondring, tilsvarende fremgangsmåde og farmaceutisk præparat, der indeholder disse | |
Stevens et al. | Benzalkonium chloride induces anterior chamber inflammation in previously untreated patients with ocular hypertension as measured by flare meter: a randomized clinical trial | |
WO2008137863A3 (en) | Methods and devices for measuring tear film and diagnosing tear disorders | |
JP5616620B2 (ja) | 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物 | |
WO2007076360A8 (en) | (indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)- pyrazines for treating rho kinase-mediated diseases and conditions | |
NO20025601D0 (no) | Arylmetylaminderivater for anvendelse som tryptaseinhibitorer | |
BRPI0710085B8 (pt) | composições oftálmicas e seus kits | |
NO20076398L (no) | Preventivt eller terapeutisk middel for keratokonjunktive forstyrrelser | |
TWI670057B (zh) | 治療乾眼用滴眼劑 | |
BRPI0409622A (pt) | derivados tricìclicos de indol e o seu uso no tratamento da doença de alzheimer | |
CN103068364B (zh) | 不含防腐剂的比马前列素和噻吗洛尔溶液 | |
WO2008059501A3 (en) | Use of lipid conjugates in the treatment of diseases or disorders of the eye | |
BR112013005438A2 (pt) | "agente para o tratamento de olho ressecado caracterizado por combinar o agonista do receptor de p2y2 e ácido hialurônico ou um sal do mesmo, método para o tratamento de olho ressecado, e uso do agonista do receptor de p2y2, e ácido hialurônico ou um sal do mesmo." | |
ES2495965T3 (es) | Uso de derivados 2,5-dihidroxibencénicos para el tratamiento de enfermedades oculares | |
EP1915998A8 (en) | Prophylactic or therapeutic agent for corneal/conjunctival disease | |
DK1296972T3 (da) | Arylmethylamin-derivater til anvendelse som tryptaseinhibitorer | |
DE602006008186D1 (de) | Neues imprägnierverfahren einer textiloberfläche | |
CY1111384T1 (el) | Διαμορφωση των επιπεδων εκφρασης toy trpv | |
JP5725786B2 (ja) | 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物 | |
CL2020001426A1 (es) | Composición tópica oftálmica que comprende ácido dobesilico para tratar enfermedades del segmento posterior del ojo. | |
WO2008055205A3 (en) | Pai-1 binding modulators for the treatment of ocular disorders | |
US20080039423A1 (en) | Ophthalmic Composition Containing Xanthan Gum and Amino Acid | |
MA40847A (fr) | Association comprenant de la spiruline et du palmitoyléthanolamide et/ou des sels ou des dérivés pharmaceutiquement acceptables de ceux-ci et leurs formulations, pour une utilisation dans la prévention et/ou le traitement d'états d'hyperactivité des tissus | |
CN105555268B (zh) | 阴离子性软隐形眼镜用眼科用组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |